Virtu Financial’s Atossa Therapeutics ATOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,451
| Closed | -$31K | – | 1454 |
|
|
2025
Q2 | $31K | Buy |
+2,451
| New | +$29.3K | ﹤0.01% | 1201 |
|
|
2025
Q1 | – | Sell |
-13,880
| Closed | -$197K | – | 1346 |
|
|
2024
Q4 | $197K | Buy |
13,880
+10,504
| +311% | +$205K | 0.01% | 897 |
|
|
2024
Q3 | $77K | Sell |
3,376
-1,632
| -33% | -$32.9K | ﹤0.01% | 947 |
|
|
2024
Q2 | $89K | Sell |
5,008
-588
| -11% | -$13K | 0.01% | 838 |
|
|
2024
Q1 | $151K | Buy |
+5,596
| New | +$89.9K | 0.01% | 845 |
|
|
2023
Q4 | – | Sell |
-5,382
| Closed | -$59K | – | 1554 |
|
|
2023
Q3 | $59K | Sell |
5,382
-406
| -7% | -$5.89K | 0.01% | 889 |
|
|
2023
Q2 | $109K | Buy |
+5,788
| New | +$70.2K | 0.01% | 1020 |
|
|
2021
Q4 | – | Sell |
-4,902
| Closed | -$240K | – | 1698 |
|
|
2021
Q3 | $240K | Buy |
4,902
+3,660
| +295% | +$213K | 0.02% | 825 |
|
|
2021
Q2 | $118K | Sell |
1,242
-16,887
| -93% | -$894K | 0.01% | 1159 |
|
|
2021
Q1 | $574K | Sell |
18,129
-225
| -1% | -$8.22K | 0.04% | 456 |
|
|
2020
Q4 | $262K | Buy |
+18,354
| New | +$425K | 0.03% | 706 |
|
|
2019
Q4 | $23K | Buy |
+980
| New | +$23K | ﹤0.01% | 1303 |
|
|
2019
Q2 | – | Sell |
-2,421
| Closed | -$128K | – | 1447 |
|
|
2019
Q1 | $128K | Sell |
2,421
-2,239
| -48% | -$65.2K | 0.01% | 1090 |
|
|
2018
Q4 | $71K | Buy |
4,660
+3,737
| +405% | +$73.9K | 0.01% | 1212 |
|
|
2018
Q3 | $24K | Buy |
+923
| New | +$30.1K | ﹤0.01% | 1388 |
|
|
2018
Q2 | – | Sell |
-486
| Closed | -$39K | – | 1970 |
|
|
2018
Q1 | $39K | Buy |
486
+234
| +93% | +$21.8K | ﹤0.01% | 1749 |
|
|
2017
Q4 | $12K | Sell |
252
-1
| -0.4% | -$73 | ﹤0.01% | 2259 |
|
|
2017
Q3 | $24K | Buy |
+253
| New | +$20.1K | ﹤0.01% | 2317 |
|
Other funds holding ATOS
GCP
